Making a Case for Interim HRPP Staffing
Don't wait to fill an HRPP position until it's too late. Understand the risks of an understaffed HRPP and how interim staffing support can help. Read more:
12 Items Auditors Look for When Reviewing an Investigator Site File
Ensure your ISF is complete and avoid findings with these examples of specifically what auditors/inspectors look for during an audit. Read more:
Fitting Your Needs: Pandemic-Proofing Protocols
The COVID-19 pandemic forced organizations to adjust to continue high-quality research, positioning research to be more patient centric and streamlined.
Introducing Fireside Chats: Conversations On Burning Research Topics
Advarra is excited to introduce Fireside Chats, a series of virtual conversations. Fireside Chat is an informal conversation between an Advarra representative, and a clinical research thought leader.
Human Research Protection Program Services
Download our info sheet to learn how Advarra can revitalize your human research protection program (HRPP) with customized consulting support
Q&A – The New Normal: Considerations for Restarting Research
Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:
Q&A Part 1 – Gene Therapy Research in the Age of COVID-19
Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1:
Q&A Part 2 – Gene Therapy Research in the Age of COVID-19
Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2:
Patient Engagement and the IRB
With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?
For Sponsors and Sites, the Research Restart Effort Begins With Communication
The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies.
Safety Precautions for Laboratory Research With COVID-19 Specimens
The pandemic has brought biosafety to the spotlight. This blog discusses guidelines and safety precautions for handling COVID-19 specimens.
Trial Design in the Time of COVID-19: Complex and Efficient
Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. Read more: